gadodiamide: Clinical Trials

7 trials of gadodiamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 recruiting, 1 unknown. 3 Phase 4, 2 Phase 3, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Recruiting 1, Unknown 1
Phase 32Completed 2
Not applicable1Terminated 1

Follow gadodiamide: new trials by email Literature Review of gadodiamide trials Research Report on gadodiamide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Motor Tests, Cognitive Tests, Unenhanced-MRI of the brain - Motor Function, Cognitive Function
Phase 4RecruitingGuerbet20762021-03-242026-01-22
Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging
Gadodiamide, Gadoteric Acid Meglumine Salt - Nephrogenic Fibrosing Dermopathy
Phase 4UnknownThe Central Hospital of Lishui City6002021-03-012021-03-01
Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer
3 Tesla Magnetic Resonance Imaging, Gadodiamide, Multiparametric Magnetic Resonance Imaging - Health Status Unknown, Prostate Carcinoma
Not applicableTerminatedOHSU Knight Cancer Institute22015-05-012019-04-03
Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)
Omniscan - Chronic Kidney Disease, Renal Insufficiency
Phase 4CompletedGE Healthcare2132009-05-012014-07-17
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
dynamic contrast enhanced magnetic resonance imaging - Glioblastoma Multiforme
TerminatedYale University52006-11-012014-07-02
A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide
Gadodiamide Injection - Aorto-iliac Stenosis, Arterial Occlusive Diseases
Phase 3CompletedGE Healthcare4072004-09-012019-04-25
A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using Gadodiamide
Gadodiamide Injection - Renal Artery Stenosis
Phase 3CompletedGE Healthcare3952003-09-012019-04-25

Conditions studied

Bites and Stings (2)  ·  Prostatic Neoplasms (2)  ·  Renal Insufficiency (2)  ·  Arterial Occlusive Diseases (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Colorectal Neoplasms (1)  ·  Glioblastoma (1)  ·  Nephrogenic Fibrosing Dermopathy (1)  ·  Neuroendocrine Tumors (1)  ·  Renal Artery Obstruction (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

GE Healthcare (3)  ·  Guerbet (1)  ·  OHSU Knight Cancer Institute (1)  ·  The Central Hospital of Lishui City (1)  ·  Yale University (1)

Countries

United States (4)  ·  Germany (3)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Italy (1)  ·  Russia (1)  ·  South Korea (1)

Top investigators

Fergus Coakley (1)  ·  Jonathan Knisely, M.D. (1)  ·  Michael Karl (1)  ·  Michael Karl, PhD (1)  ·  Rubin Sheng, MD (1)

NIH funding

P30CA069533 (1)